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Purpose: Among available biomaterials, bioceramics have drawn special interest due to their bioactivity and the possibility of 
tailoring their composition. The degradation rate and formulation of bioceramics can be altered to mimic the compositions 
of the mineral phase of bone. The aim of this study was to investigate the bone formation effect of amorphous calcium phos-
phate glass cement (CPGC) synthesized by a melting and quenching process. 
Methods: In five male beagle dogs, 4 × 4 mm 1-wall intrabony defects were created bilaterally at the mesial or distal aspect of 
the mandibular second and fourth premolars. Each of the four defects was divided according to graft materials: CPGC with 
collagen membrane (CM), biphasic calcium phosphate (BCP) with CM, CM alone, or a surgical flap operation only. The dogs 
were sacrificed  8 weeks post-surgery, and block sections of the defects were collected for histologic and histometric analysis.  
Results: There were significant differences in bone formation and cementum regeneration between the experimental and 
control groups. In particular, the CPGC and BCP groups showed greater bone formation than the CM and control groups.
Conclusions: In conclusion, CPGC was replaced rapidly with an abundant volume of new bone; CPGC also contributed 
slightly to regeneration of the periodontal apparatus.
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INTRODUCTION
Regenerative treatment of large periodontal bone defects 
remains a challenge for periodontists. Autologous bone graft-
ing is considered to be the gold standard in reconstructive 
bone surgery due to its superior osteogenic potential com-
pared to allogenic transplants. However, the availability of 
autogenous graft material is limited. Graft harvest lengthens 
operation time and can be associated with adverse effects, 
such as bleeding, pain, and infection. Allogenic bone materi-
al carries the risk of infectious disease transmission, includ-
ing human immunodeficiency virus or hepatitis [1,2]. Due to 
these drawbacks, inorganic composites are of special interest 
as bone substitutes. Synthetic grafts must be composed of a 
three-dimensional porous material to induce bone formation 
and osteoconduction. 
Calcium phosphates (CP) have been received the most at-
tention as synthetic agents, and they are widely used because 
of their good biocompatibility and osteointegrative proper-
ties [3]. Synthetic hydroxyapatite (HA) is one type of CP and 
can be anchored to native bone by the establishment of a 
physicochemical bond with living tissue [4]. Extensive re-
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search has been performed on HA over the past 20 years as a 
leading candidate of CP, and it has been used clinically in var-
ious forms due to its osteoconductive properties. Many inves-
tigators have reported that HA resulted in improved attach-
ment and pocket reduction in clinical studies [5].
However, the success of these materials is limited primarily 
due to inappropriate physical properties such as inadequate 
toughness, low elasticity, low resorbability, and lack of osteo-
genic properties [6]. Calcium phosphate glass (CPG) materials 
are known to have osteoconductive characteristics, serving 
as an active participatory template for the formation of new 
bone [7]. CPG is bioactive and has a chemical composition 
very similar to that of the mineral phase of bone. Recently, 
LeGeros and Lee reported on CPG cement (CPGC) in a CaO-
CaF2-P2O5-MgO-ZnO system, where it was observed to pro-
mote bone-like tissue formation in vitro [8]. Moreover, CPGC 
is easily synthesized by a melting and subsequent quenching 
process and has a low viscosity in the molten state [9]. Accord-
ingly, CPGC can offer stability in the repair of bone defects 
during the initial 6 weeks. Previous studies have reported that 
CPGC has more desireable physical properties than BCP [10]. 
However, the bone formation and periodontal regeneration 
abilities of CPGC relative to BCP have not been documented. 
The objective of this study was to evaluate the bone forma-
tion effect of CPGC in a system of CaO-CaF2-P2O5-MgO-
ZnO and to determine the influence of CPGC on periodontal 
regeneration in 1-wall intrabony defects in the mandibles of 
beagle dogs by comparing CPGC performance with that of 
BCP.
MATERIALS AND METHODS
Animals
Five male beagle dogs (25-30 kg), 18 to 24 months old were 
used. The animals had intact dentition and a healthy perio-
dontium. Animal selection, management, surgical protocol 
and preparation followed routines approved by the Institu-
tional Animal Care and Use Committee, Yonsei Medical Cen-
ter, Seoul, Korea.
Experimental groups
Four defects were created in each dog, and one defect was 
assigned to each experimental group as follows: 1) CPGC 
group: defect filled with CPGC covered by collagen; 2) BCP 
group: defect filled with BCP covered by collagen; 3) CM 
group: defect covered by collagen membrane; 4) Control 
group: non-grafted.
Graft materials
BCP (OsteonTM, Genoss Co. Ltd., Suwon, Korea) is composed 
of 70% HA and 30% β-tricalcium phosphate (β-TCP). HA 
coated with β-TCP establishes an interconnected scaffold with 
a porosity of 300-500 nm.
CPGC was prepared from a CaO-CaF2-P2O5-MgO-ZnO sys-
tem. Mixed batches were melted in a platinum crucide at 
850°C and poured onto a graphite plate at room temperature 
as quenched glass was ground in an alumina mortar. Particle 
size of the powdered sample was 0.08 to 555.7 mm (average 
size, 167.95 mm). The CPG was mixed with Na2CO3 powder in 
NaOH solution to maintain stability of shape and control the 
setting time. The final CPGC product was amorphous calci-
um polyphosphate.
CM (CollaTape®, Integra Lifesciences Co., Plainsboro, USA) 
was fabricated using collagen obtained from bovine deep flex-
or (Achilles) tendon.
Surgical procedure
Surgery was performed under general anesthesia induced 
by intravenous injection of atropine (0.04 mg/kg) and intra-
muscular injection of xylazin (Rompun, Bayer Korea, Seoul, 
Korea) and ketamine (Ketalar, Yuhan Co., Seoul, Korea) fol-
lowed by the administration of inhaled enflurance. Routine 
dental infiltration anesthesia (2% lidocaine with HCl epineph-
rine, 1:100,000, Kwangmyung Pharm., Seoul, Korea) was used 
at the surgical site. The mandibular 1st and 3rd premolar teeth 
were extracted in advance of the experimental surgeries, and 
the extraction sites were allowed to heal for 8 weeks. One-wall 
intrabony defects measuring 4 × 4 mm were created bilater-
ally at the mesial aspect of the mandibular 2nd and 4th pre-
molar areas. A reference notch was made with a round bur 
on the root surface at the base of each defect. In each dog, 
two defects were filled with CPGC or BCP then covered with 
CM. One defect was not filled with graft material and was 
covered with CM. The last defect was treated by surgical flap 
operation only. The surgical flap was sutured with 5-0 resorb-
able suture material (Polyglactin 910, braided absorbable su-
ture, Ethicon, Johnson & Johnson Int., Edinburgh, UK). Intra-
muscular antibiotics were administered for 3 days and a daily 
dressing of 0.2% chlorhexidine solution (Hexamedin, 2% 
chlorhexidine, Bukwang Pharm. Co., Seoul, Korea) was applied 
for 7 days as postsurgical care. The suture was removed after 
10 days. The animals were sacrificed 8 weeks after surgery 
and block sections of the defect sites were collected and pre-
pared for histological and histometric evaluation (Fig. 1).
Analysis
Histologic analysis
The block sections were fixed in 10% buffered formalin and 
decalcified with 5% nitric acid for 14 days. Paraffin wax blocks 
were made and sectioned in the mesio-distal direction with a 
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thickness of 4 μm. Each section was stained in hematoxylin 
and eosin. General histological findings were observed with a 
stereoscope (Leica DM-LB, Leica, Wetzlar, Germany) and mi-
croscope.
Histometric analysis
After conventional microscopic examination, computer-as-
sisted histometric measurements were obtained using an au-
tomated image analysis system (Image-Pro Plus®, Media Cy-
bernetics, Silver Spring, USA) coupled with a video camera 
mounted in a light microscope (Leica DM-LB, Leica, Wetzlar, 
Germany). The measurment parameters were as follows: the 
cementoenamel junction (CEJ) and the notch were used as 
reference points (bN) and the histometric parameters included 
defect height (DH), junctional epithelium (JE), connective tis-
sue attachment (CT), cementum regeneration (NC) and bone 
regeneration (NB) (Fig. 2).
Statistical analysis
Histomorphometric recordings from the four sections from 
each defect were used to calculate the mean score for each an-
imal. Statistical analysis was compared by the Kruskal-Wallis 
test. The ANOVA Bonferroni method was used to evaluate the 
statistical significance among the 4 groups (P<0.05).
RESULTS
Clinical findings
During the postoperative period, healing was uneventful 
for all animals. There were no signs of inflammation and no 
wound exposures. 
Histological findings
Histologically, the junctional epithelium migrated apically 
and inflammatory cell infiltration was minimal in all defect 
sites. Connective tissue attachment was observed perpendic-
ular to the long axis of the tooth beneath the junctional epi-
thelium. The periodontal ligament was organized with pri-
marily irregular collagen fibers. 
The CPGC group showed a large amount of new cemen-
tum and new bone formation, more than that seen in the con-
trol and CM groups. Resorption of graft material was detect-
able and several calcium phosphate remnants were surround-
ed by provisional connective tissue, which would eventually 
transform into bone. The regenerated bone tissue was em-
Figure 1. Clinical photograph (A) and radiograph (B) showing surgically prepared 1-wall intrabony defects at the mesial aspect of the second 
premolar and fourth premolar (A: collagen membrane group or control group, B: calcium phosphate glass cement group or biphasic calci-
um phosphate).
A A
B
B
A B
Figure 2. Schematic diagram depicting the landmarks and the pa-
rameters used in histometric analysis. The heights of new bone, 
new cementum, epithelial, and connective tissue attachment in 4 × 
4 mm 1-wall intrabony defects were measured using an automated 
image analysis system. 
CEJ: Cementoenamel Junction
JE: Junctional epithelium
CT: Connective tissue attachment
NC: Cementum regeneration
NB: Bone regeneration
 Periodontal ligament
bN: Notch
Tooth
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bedded and formed within graft materials. The edge of the 
particles exhibited irregular features and the presence of 
multinucleated giant cells, indicating the resorption or dis-
solution process. In the mature new bone portion, osteoclasts 
observed on the surface of a secondary osteon within the 
bone trabeculae suggested an active remodeling process. New 
cementum that was thinner than the original cementum was 
observed along the root surface, extending to the level of the 
regenerated bone. A residual collagen membrane was not ob-
served in the CPGC, BCP, or CM groups (Fig. 3).
The BCP group showed newly formed woven bone and con-
nective tissue around the remaining HA coated with β-TCP 
particles. There were no osteoblasts or osteoclasts around BCP 
particles adjacent to the defect base. However, loose connec-
tive tissue including undifferentiated cells and blood vessels 
was observed around the coronal particles. Regenerated ce-
mentum and periodontal ligament space could be observed 
along the root surface, demonstrating that root resorption or 
root ankylosis had not occurred (Fig. 4).
The CM group showed some regeneration of bone and ce-
mentum occurring along the root surface. Long junctional 
epithelium was formed more apically than in the other groups. 
The magnitude of resorption appeared greater in the root sur-
face without cementum than in the root surface covered by 
new cementum (Fig. 5). 
The control group showed only rare regeneration of bone 
and cementum. A few inflammatory cells were observed at 
the surgical site. No ankylosis was observed (Fig. 5).
Histometric findings
The results of histometric analysis are summarized in Table 
1. The average defect height was not significantly different 
among groups. 
There were significant differences in new bone height be-
tween the CPGC and BCP groups and the CM and control 
groups. In addition, new cementum height was higher in the 
Figure 3. Surgical sections from the calcium phosphate glass cement (CPGC)  group. (A) Histologic view of the CPGC group. Most particles 
were resorbed and new bone was formed above the notch (H&E, ×20; base of reference notch [bN]: arrow; height of new bone: black dia-
mond; CPGC particle: black star; bar = 2 mm). (B) Histologic view of magnified black square area (× 200). Osteoblast-like cells were observed 
around remaining particles. Peripheral new bone was woven bone with isolated osteocytes (H&E, × 200; CPGC particle: black star; NB: new 
bone; WB: woven bone; bar = 0.1 mm).
A B
bN
WB
NB
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CPGC and BCP groups than in the CM and control groups. 
Epithelial attachment was highest in the CM group. The CPGC 
group showed less epithelial attachment than the BCP group, 
but this difference was not significant.
DISCUSSION
This study was designed to investigate bone formation and 
periodontal regenerative abilities of CPGC compared with 
BCP. For this purpose, we used 1-wall intrabony defects, which 
implies that the defect does not heal by itself during the life-
time of the animal. Without treatment (control group), less 
than 20% of the bone was regenerated. Therefore, this mod-
el is useful for the evaluation of the regenerative effect of 
bone substitutes in dogs.
The height of new bone formation was 1.90 mm in the CPGC 
group and 2.42 mm in the BCP group; this difference was not 
statistically significant. Likewise, the height of new cemetum 
was 1.34 mm in the CPGC group and 1.70 mm in the BCP 
group, which lacked statistical significance. These findings 
suggest that CPGC has an effect similar to BCP on the regen-
eration of periodontal tissues, including new bone and ce-
mentum. Previous studies found similar effects of CPGC on 
new bone formation. Nery et al. [11] reported that the combi-
nation of calcium (Ca) and phosphate (P) in a ceramic implant 
enhanced repopulation of cells, new periodontal tissue at-
tachment, and bone regeneration within the space of a peri-
odontal osseous defect. In other words, the activities of osteo-
blasts were promoted by calcium and phosphate ions which 
were separated during the process of melting the graft mate-
rial. Both the CPGC and BCP used in this study were a com-
bination of calcium and phosphate and thus would contrib-
ute to new bone formation and periodontal regeneration in 
the bony defects. However, the Ca/P ratio is different in CPGC 
than in BCP. The Ca/P ratio of CPGC is about 0.6 and that of 
BCP ranges between 1.50 and 1.67 [12]. This difference may 
Figure 4. Surgical sections from the biphasic calcium phosphate (BCP) group. (A) Histologic view of BCP group. There were more remain-
ing particles than in the calcium phosphate glass cement (CPGC) group. New bone was formed above the notch (H&E, × 20; base of refer-
ence notch [bN]: arrow; the height of new bone: black diamond; BCP particle: black star; bar = 2 mm). (B) Histologic view of magnified black 
square area (× 200). Multi-nucleated giant cells were arranged around particles and woven bone was formed (H&E, × 200; BCP particle: 
black star; NB: new bone; WB: woven bone; bar = 0.1 mm).
A B
bN
WB
NB
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result in different resorption rates of the two graft materials, 
because Ca2+ ions act as a network modifier in glass and se-
cure bond strength between particles. As the Ca2+ ion portion 
increases, the resorption rate of glass decreases [13]. Therefore, 
when comparing Figs. 3,4, the number of remaining particles 
was smaller with CPCG than BCP after 8 weeks.  
Generally, the barrier membrane is surgically removed af-
ter 4–6 weeks in guided tissue regeneration or guided bone 
regeneration. Connective tissue and bone regeneration may 
then occur within the bony lesion protected by the barrier 
[14]. Likewise, CPGC provides sufficient space for optimal 
wound stability while being resorbed after 8 weeks. This in-
dicates that CPGC has the proper physical properties to serve 
as a graft material. 
Table 1. Comparison of histometric analysis among groups (mean ± SD in mm).
CPGC group BCP group CM group Control group
Defect height 5.09 ± 0.58 5.33 ± 0.81 5.54 ± 0.59 5.04 ± 0.51
New bone height 1.90 ± 0.44a,b) 2.42 ± 1.34a,b) 1.09 ± 0.26 0.70 ± 0.32
New cementum height 1.34 ± 0.73a) 1.70 ± 1.09a) 1.17 ± 0.65 0.95 ± 1.34
Epithelial attachment 1.88 ± 1.02b,c) 2.51 ± 1.10 3.13 ± 0.94a) 1.62 ± 0.88b,c)
Connective tissue attachment 1.55 ± 0.75 0.89 ± 0.55 0.97 ± 0.96 1.13 ± 1.70
CPGC: calcium phosphate glass cement, BCP: biphasic calcium phosphate, CM: collagen membrane.
a)Statistically significant difference from control (P<0.05). 
b)Statistically significant difference from CM group (P<0.05). 
c)Statistically significant difference from BCP group (P<0.05).
Figure 5. Surgical sections from the collagen membrane (CM) group and the control group. (A) Histologic view of the CM group. A small 
amount of new bone was formed above the notch. Thick connective tissue was present (H&E, × 20; base of reference notch [bN]: arrow; 
height of new bone: black diamond; bar = 2 mm). (B) Histologic view of the control group. There was very little new bone above the notch. 
Long junctional epithelium was observed and inflammatory cell infiltrate was relatively strong (H&E, × 20; base of reference notch [bN]: ar-
row; height of new bone: black diamond; bar = 2 mm).
A B
bN
bN
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It should be mentioned that CPGC may be potentially use-
ful in hard tissue surgery because of its solubility behavior, 
since its solubility may be controlled by altering its chemical 
composition [15]. Again, CPG, which is the basis of CPGC 
synthesis, is associated with the release of biologically thera-
peutic molecules. CPG can dissolve some elements, oxides, 
or biological molecules that are insoluble or poorly soluble in 
glasses of other materials and crystalline compounds. There-
fore, CPGC has the ability to not only promote new bone for-
mation and periodontal regeneration but also work synergis-
tically when synthesized with various materials. Many animal 
studies have demonstrated the ability of CPGC to function as 
a carrier of growth factor or human recombinant bone mor-
phogenetic protein and have reported positive results [16,17]. 
More studies are necessary to further clarify the potential ap-
plications of CPGC. 
The findings of this study provide limited evidence of the 
excellent physical properties associated with CPCG. Future 
areas of interest might include determination of the resorp-
tion period and resorption rate of this compound. In addi-
tion, there should be further research to demonstrate the ap-
plication of CPGC for widespread use.
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